Spots Global Cancer Trial Database for untreated childhood brain stem glioma
Every month we try and update this database with for untreated childhood brain stem glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma | NCT00387790 | Untreated Child... | motexafin gadol... 3-dimensional c... | - 21 Years | National Cancer Institute (NCI) | |
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas | NCT00042991 | Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | gefitinib radiation thera... pharmacological... laboratory biom... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
Carboplatin in Patients With Progressive Gliomas | NCT00002749 | Brain and Centr... | carboplatin | - | Duke University | |
Tumor Tissue, Blood Samples, and Family History in Predicting Tumor Development and Response to Treatment in Young Patients With Low-Grade Glioma | NCT00891722 | Brain and Centr... | biologic sample... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00003909 | Untreated Child... | motexafin gadol... radiation thera... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma | NCT00107471 | Brain Tumors Central Nervous... | filgrastim topotecan hydro... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma | NCT00079339 | Untreated Child... | radiation thera... tipifarnib | 3 Years - 21 Years | National Cancer Institute (NCI) | |
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma | NCT00514397 | Brain and Centr... | motexafin gadol... temozolomide adjuvant therap... quality-of-life... radiation thera... | 2 Years - 21 Years | National Cancer Institute (NCI) | |
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma | NCT00021229 | Brain and Centr... | imatinib mesyla... local irradiati... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma | NCT00021229 | Brain and Centr... | imatinib mesyla... local irradiati... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas | NCT00278278 | Brain and Centr... | cisplatin etoposide ifosfamide lomustine methotrexate prednisone vincristine sul... | 3 Years - 18 Years | National Cancer Institute (NCI) | |
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas | NCT02175745 | Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | 18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona... | 16 Years - | Stanford University | |
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00003935 | Brain Tumors Central Nervous... | etoposide vincristine sul... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma | NCT00003459 | Brain Stem Glio... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma | NCT00357253 | Brain and Centr... | capecitabine radiation thera... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor | NCT00004068 | Brain and Centr... | irinotecan hydr... temozolomide conventional su... radiation thera... | 3 Years - 21 Years | St. Jude Children's Research Hospital | |
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | NCT00276640 | Primary Central... | vincristine, ca... vincristine, ca... radiation thera... | 1 Day - 18 Years | Societe Internationale d'Oncologie Pediatrique | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | NCT00003625 | Brain Tumors Central Nervous... | cyclosporine etoposide vincristine sul... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00024336 | Brain and Centr... | tamoxifen citra... radiation thera... | - 19 Years | National Cancer Institute (NCI) | |
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas | NCT01514201 | Anaplastic Astr... Brain Stem Glio... Childhood Mixed... Fibrillary Astr... Giant Cell Glio... Glioblastoma Gliosarcoma Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | 3-Dimensional C... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Veliparib | - 21 Years | National Cancer Institute (NCI) | |
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | NCT00281905 | Brain and Centr... Neuroblastoma | carboplatin cisplatin cyclophosphamid... methotrexate vincristine sul... radiation thera... | - 3 Years | National Cancer Institute (NCI) | |
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | NCT00276640 | Primary Central... | vincristine, ca... vincristine, ca... radiation thera... | 1 Day - 18 Years | Societe Internationale d'Oncologie Pediatrique | |
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00003935 | Brain Tumors Central Nervous... | etoposide vincristine sul... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas | NCT00005602 | Brain and Centr... | carboplatin cereport radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00031577 | Brain and Centr... | paclitaxel radiation thera... | 3 Years - 21 Years | Children's Hospital of Philadelphia | |
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma | NCT00360854 | Brain and Centr... | erlotinib hydro... mutation analys... polymorphism an... laboratory biom... pharmacological... radiation thera... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | NCT00003625 | Brain Tumors Central Nervous... | cyclosporine etoposide vincristine sul... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | NCT00003625 | Brain Tumors Central Nervous... | cyclosporine etoposide vincristine sul... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas | NCT01514201 | Anaplastic Astr... Brain Stem Glio... Childhood Mixed... Fibrillary Astr... Giant Cell Glio... Glioblastoma Gliosarcoma Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | 3-Dimensional C... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Veliparib | - 21 Years | National Cancer Institute (NCI) | |
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma | NCT00079339 | Untreated Child... | radiation thera... tipifarnib | 3 Years - 21 Years | National Cancer Institute (NCI) | |
Carboplatin in Patients With Progressive Gliomas | NCT00002749 | Brain and Centr... | carboplatin | - | Duke University | |
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas | NCT00095771 | Brain and Centr... | arsenic trioxid... radiation thera... | 3 Years - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma | NCT00472017 | Brain and Centr... | vandetanib | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma | NCT00003459 | Brain Stem Glio... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
Temozolomide in Treating Patients With Progressive Low-Grade Glioma | NCT00003466 | Brain and Centr... | temozolomide | 4 Years - | Duke University | |
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors | NCT02194452 | Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom... | 6 Months - 29 Years | University of Iowa | |
Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma | NCT00387790 | Untreated Child... | motexafin gadol... 3-dimensional c... | - 21 Years | National Cancer Institute (NCI) | |
Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00024336 | Brain and Centr... | tamoxifen citra... radiation thera... | - 19 Years | National Cancer Institute (NCI) | |
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors | NCT00238173 | Bone Marrow Sup... Brain and Centr... Drug/Agent Toxi... Long-term Effec... | filgrastim acetylcysteine carboplatin cyclophosphamid... etoposide phosp... mannitol sodium thiosulf... | 1 Year - 18 Years | OHSU Knight Cancer Institute | |
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | NCT00276640 | Primary Central... | vincristine, ca... vincristine, ca... radiation thera... | 1 Day - 18 Years | Societe Internationale d'Oncologie Pediatrique | |
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas | NCT01514201 | Anaplastic Astr... Brain Stem Glio... Childhood Mixed... Fibrillary Astr... Giant Cell Glio... Glioblastoma Gliosarcoma Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | 3-Dimensional C... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Veliparib | - 21 Years | National Cancer Institute (NCI) |